{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:04:33Z","timestamp":1773983073627,"version":"3.50.1"},"reference-count":61,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.4161\/hv.23334","type":"journal-article","created":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T19:23:09Z","timestamp":1359573789000},"page":"812-822","source":"Crossref","is-referenced-by-count":37,"title":["Childhood varicella-zoster virus vaccination in Belgium: Cost-effective only in the long run or without exogenous boosting?"],"prefix":"10.1080","volume":"9","author":[{"given":"Joke","family":"Bilcke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Jan van Hoek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Beutels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,10,27]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Gershon A, Takahashi M, Seward J. Varicella Vaccine. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. Philadelphia: Saunders 2008:915-58.","DOI":"10.1016\/B978-1-4160-3611-1.50039-8"},{"key":"R2","first-page":"9","article-title":"The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc R Soc Med"},{"key":"R3","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"key":"R4","unstructured":"VENICE. Varicella and Herpes Zoster surveillance and vaccination recommendations 2010-2011. 2010."},{"key":"R5","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1017\/S0950268811002640","article-title":"The health and economic burden of chickenpox and herpes zoster in Belgium","volume":"140","author":"Bilcke","year":"2012","journal-title":"Epidemiol Infect"},{"key":"R6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1586\/14760584.7.6.753","article-title":"Cost-effectiveness of varicella vaccination programs: an update of the literature","volume":"7","author":"Rozenbaum","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"R7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00019053-200321010-00002","article-title":"Economic evaluations of varicella vaccination programmes: a review of the literature","volume":"21","author":"Thiry","year":"2003","journal-title":"Pharmacoeconomics"},{"key":"R8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/infdis\/148.2.200","article-title":"Immunologic evidence of reinfection with varicella-zoster virus","volume":"148","author":"Arvin","year":"1983","journal-title":"J Infect Dis"},{"key":"R9","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","article-title":"Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"key":"R10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/cir436","article-title":"Does monastic life predispose to the risk of Saint Anthony\u2019s fire (herpes zoster)?","volume":"53","author":"Gaillat","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R11","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1017\/S0950268810001949","article-title":"Herpes zoster in Australia: evidence of increase in incidence in adults attributable to varicella immunization?","volume":"139","author":"Jardine","year":"2011","journal-title":"Epidemiol Infect"},{"key":"R12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/ciq077","article-title":"Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination","volume":"52","author":"Leung","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/vim.2010.0031","article-title":"Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents","volume":"24","author":"Ogunjimi","year":"2011","journal-title":"Viral Immunol"},{"key":"R14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/cid\/cir841","article-title":"Zoster in monasteries: some clarification needed","volume":"54","author":"Ogunjimi","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R15","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1016\/j.vaccine.2011.08.023","article-title":"Contacts with children and young people and adult risk of suffering herpes zoster","volume":"29","author":"Salleras","year":"2011","journal-title":"Vaccine"},{"key":"R16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(02)09837-9","article-title":"Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study","volume":"360","author":"Thomas","year":"2002","journal-title":"Lancet"},{"key":"R17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2458-5-68","article-title":"The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003","volume":"5","author":"Yih","year":"2005","journal-title":"BMC Public Health"},{"key":"R18","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"R19","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R20","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.vaccine.2011.11.026","article-title":"The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom","volume":"30","author":"van Hoek","year":"2012","journal-title":"Vaccine"},{"key":"R21","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.vaccine.2011.09.079","article-title":"Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice?","volume":"30","author":"Bilcke","year":"2012","journal-title":"Vaccine"},{"key":"R22","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1086\/430325","article-title":"Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002","volume":"191","author":"Jumaan","year":"2005","journal-title":"J Infect Dis"},{"key":"R23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00019053-200220010-00001","article-title":"Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis","volume":"20","author":"Beutels","year":"2002","journal-title":"Pharmacoeconomics"},{"key":"R24","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.vaccine.2006.10.034","article-title":"Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006)","volume":"25","author":"Beutels","year":"2007","journal-title":"Vaccine"},{"key":"R25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00019053-200927040-00002","article-title":"Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources","volume":"27","author":"Bilcke","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"R26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hec.625","article-title":"Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000)","volume":"10","author":"Beutels","year":"2001","journal-title":"Health Econ"},{"key":"R27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-6296(96)00506-1","article-title":"Economic foundations of cost-effectiveness analysis","volume":"16","author":"Garber","year":"1997","journal-title":"J Health Econ"},{"key":"R28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/phe\/phr032","article-title":"Vaccination Policy and Ethical Challenges Posed by Herd Immunity, Suboptimal Uptake and Subgroup Targeting","volume":"4","author":"Luyten","year":"2011","journal-title":"Public Health Eth-Uk"},{"key":"R29","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1086\/522150","article-title":"Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005","volume":"197","author":"Chaves","year":"2008","journal-title":"J Infect Dis"},{"key":"R30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/pch\/16.7.415","article-title":"Preventing varicella: Recommendations for routine two-dose varicella immunization in children","volume":"16","author":"Salvadori","year":"2011","journal-title":"Paediatr Child Health"},{"key":"R31","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/cid\/cis638","article-title":"Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy","volume":"55","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s15010-007-6337-z","article-title":"Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age","volume":"35","author":"Goh","year":"2007","journal-title":"Infection"},{"key":"R33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.inf.0000195626.35239.58","article-title":"Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children","volume":"25","author":"Knuf","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4161\/hv.2.5.3246","article-title":"Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad)","volume":"2","author":"Kuter","year":"2006","journal-title":"Hum Vaccin"},{"key":"R35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","article-title":"Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children","volume":"24","author":"Shinefield","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R36","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1093\/infdis\/174.Supplement_3.S335","article-title":"Costs and benefits of routine varicella vaccination in German children","volume":"174","author":"Beutels","year":"1996","journal-title":"J Infect Dis"},{"key":"R37","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0264-410X(02)00431-0","article-title":"The cost-effectiveness of routine childhood varicella vaccination in Germany","volume":"21","author":"Banz","year":"2003","journal-title":"Vaccine"},{"key":"R38","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0264-410X(01)00437-6","article-title":"The cost-effectiveness of varicella vaccination in Canada","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"key":"R39","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/adc.88.10.862","article-title":"Varicella vaccination in England and Wales: cost-utility analysis","volume":"88","author":"Brisson","year":"2003","journal-title":"Arch Dis Child"},{"key":"R40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0264-410X(99)00261-3","article-title":"The cost-effectiveness of varicella vaccine programs for Australia","volume":"18","author":"Scuffham","year":"1999","journal-title":"Vaccine"},{"key":"R41","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1016\/j.vaccine.2004.03.043","article-title":"An economic evaluation of varicella vaccination in Italian adolescents","volume":"22","author":"Thiry","year":"2004","journal-title":"Vaccine"},{"key":"R42","unstructured":"Beutels P. Economic evaluation of vaccination programmes in humans: a methodological exploration with applications to hepatitis B, varicella-zoster, measles, pertussis, hepatitis A and pneumococcal vaccination. Antwerp: University of Antwerp (ISBN 90-9015528-7), 2002:523."},{"key":"R43","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00431-002-1053-2","article-title":"The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium)","volume":"161","author":"Thiry","year":"2002","journal-title":"Eur J Pediatr"},{"key":"R44","doi-asserted-by":"crossref","unstructured":"Bilcke J, Marais C, Ogunjimi B, van Hoek AJ, Lejeune O, Callens M, et al. Cost-utility of vaccination against chickenpox in children and against herpes zoster in elderly in Belgium. KCE reports 151 2011; (https:\/\/kce.fgov.be\/nl\/publication\/report\/kosteneffectiviteit-van-vaccinatie-tegen-windpokken-bij-kinderen-en-tegen-zona-bi).","DOI":"10.57598\/R151A"},{"key":"R45","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1471-0528.2011.02983.x","article-title":"Varicella-zoster virus (chickenpox) infection in pregnancy","volume":"118","author":"Lamont","year":"2011","journal-title":"BJOG"},{"key":"R46","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.vaccine.2011.01.037","article-title":"Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England","volume":"29","author":"van Hoek","year":"2011","journal-title":"Vaccine"},{"key":"R47","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S0950268800004714","article-title":"Modelling the impact of immunization on the epidemiology of varicella zoster virus","volume":"125","author":"Brisson","year":"2000","journal-title":"Epidemiol Infect"},{"key":"R48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/oxfordjournals.aje.a117238","article-title":"Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States","volume":"140","author":"Halloran","year":"1994","journal-title":"Am J Epidemiol"},{"key":"R49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/biostatistics\/kxq059","article-title":"Model structure analysis to estimate basic immunological processes and maternal risk for parvovirus B19","volume":"12","author":"Goeyvaerts","year":"2011","journal-title":"Biostatistics"},{"key":"R50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1467-9876.2009.00693.x","article-title":"Estimating infectious disease parameters from data on social contacts and serological status","volume":"59","author":"Goeyvaerts","year":"2010","journal-title":"J R Stat Soc"},{"key":"R51","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.mbs.2008.12.009","article-title":"Using empirical social contact data to model person to person infectious disease transmission: an illustration for varicella","volume":"218","author":"Ogunjimi","year":"2009","journal-title":"Math Biosci"},{"key":"R52","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1002\/sim.3089","article-title":"Modelling multisera data: the estimation of new joint and conditional epidemiological parameters","volume":"27","author":"Hens","year":"2008","journal-title":"Stat Med"},{"key":"R53","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.vaccine.2011.10.036","article-title":"Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium","volume":"30","author":"Bilcke","year":"2012","journal-title":"Vaccine"},{"key":"R54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/INF.0b013e3181b41506","article-title":"Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: a Canadian prospective study","volume":"29","author":"Brisson","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R55","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.vaccine.2005.09.026","article-title":"The burden of Herpes Zoster: a prospective population based study","volume":"24","author":"Scott","year":"2006","journal-title":"Vaccine"},{"key":"R56","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/AJP.0b013e3181eef686","article-title":"A prospective study of the herpes zoster severity of illness","volume":"26","author":"Drolet","year":"2010","journal-title":"Clin J Pain"},{"key":"R57","unstructured":"Hoppenbrouwers K, Vandermeulen C, Roelants M, Boonen M, Depoorter A, Van Damme P, et al. Studie van de vaccinatiegraad bij jonge kinderen en adolescenten in Vlaanderen in 2008. KULeuven, in opdracht van Ministerie Welzijn en Gezin van de Vlaamse Gemeenschap 2008; http:\/\/www.zorg-en-gezondheid.be\/uploadedFiles\/NLsite\/Preventie\/Infectieziekten_en_vaccinaties\/Vaccinaties\/professionelen\/vaccinatiegraad\/VCOV_fulltekst_2009_02_06-text.pdf."},{"key":"R58","unstructured":"Swennen B, Robert E. Enqu\u00eate de couverture vaccinale en Communaut\u00e9 fran\u00e7aise, Bruxelles except\u00e9. Provac 2009."},{"key":"R59","unstructured":"Swennen B. Enqu\u00eate de couverture vaccinale en Communaut\u00e9 fran\u00e7aise, Bruxelles except\u00e9. Provac 2006."},{"key":"R60","unstructured":"Cleemput I, Neyt M, Van De Sande S, Thiry N. Belgian guidelines for economic evaluations and budget impact analyses: second edition. KCE reports 183C 2011; (https:\/\/kce.fgov.be\/publication\/report\/belgian-guidelines-for-economic-evaluations-and-budget-impact-analyses-second-edi)."},{"key":"R61","doi-asserted-by":"crossref","unstructured":"Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. New York: Oxford University Press, 2006.","DOI":"10.1093\/oso\/9780198526629.001.0001"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.4161\/hv.23334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T18:56:06Z","timestamp":1745952966000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/abs\/10.4161\/hv.23334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":61,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,10,27]]},"published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.4161\/hv.23334"],"URL":"https:\/\/doi.org\/10.4161\/hv.23334","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}